481 related articles for article (PubMed ID: 20383714)
1. alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.
Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
Acta Neuropathol; 2010 Jun; 119(6):723-35. PubMed ID: 20383714
[TBL] [Abstract][Full Text] [Related]
2. α-Synuclein in the olfactory system of a mouse model of Parkinson's disease: correlation with olfactory projections.
Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Martinez-Marcos A
Brain Struct Funct; 2012 Apr; 217(2):447-58. PubMed ID: 21928152
[TBL] [Abstract][Full Text] [Related]
3. Staging of alpha-synuclein in the olfactory bulb in a model of Parkinson's disease: cell types involved.
Ubeda-Bañon I; Saiz-Sanchez D; de la Rosa-Prieto C; Mohedano-Moriano A; Fradejas N; Calvo S; Argandoña-Palacios L; Garcia-Muñozguren S; Martinez-Marcos A
Mov Disord; 2010 Aug; 25(11):1701-7. PubMed ID: 20574962
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
5. Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb.
Sengoku R; Saito Y; Ikemura M; Hatsuta H; Sakiyama Y; Kanemaru K; Arai T; Sawabe M; Tanaka N; Mochizuki H; Inoue K; Murayama S
J Neuropathol Exp Neurol; 2008 Nov; 67(11):1072-83. PubMed ID: 18957894
[TBL] [Abstract][Full Text] [Related]
6. The anterior olfactory nucleus in Parkinson's disease.
Pearce RK; Hawkes CH; Daniel SE
Mov Disord; 1995 May; 10(3):283-7. PubMed ID: 7651444
[TBL] [Abstract][Full Text] [Related]
7. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
9. Can olfactory bulb biopsy be justified for the diagnosis of Parkinson's disease? Comments on "olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders".
Parkkinen L; Silveira-Moriyama L; Holton JL; Lees AJ; Revesz T
Acta Neuropathol; 2009 Feb; 117(2):213-4; author reply 217-8. PubMed ID: 19031077
[No Abstract] [Full Text] [Related]
10. Spinal cord lesions in sporadic Parkinson's disease.
Del Tredici K; Braak H
Acta Neuropathol; 2012 Nov; 124(5):643-64. PubMed ID: 22926675
[TBL] [Abstract][Full Text] [Related]
11. Neuropathologic analysis of Lewy-related α-synucleinopathy in olfactory mucosa.
Funabe S; Takao M; Saito Y; Hatsuta H; Sugiyama M; Ito S; Kanemaru K; Sawabe M; Arai T; Mochizuki H; Hattori N; Murayama S
Neuropathology; 2013 Feb; 33(1):47-58. PubMed ID: 22672612
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analyses of the human olfactory bulb.
Smith RL; Baker H; Greer CA
J Comp Neurol; 1993 Jul; 333(4):519-30. PubMed ID: 7690371
[TBL] [Abstract][Full Text] [Related]
13. Regional differences in the severity of Lewy body pathology across the olfactory cortex.
Silveira-Moriyama L; Holton JL; Kingsbury A; Ayling H; Petrie A; Sterlacci W; Poewe W; Maier H; Lees AJ; Revesz T
Neurosci Lett; 2009 Apr; 453(2):77-80. PubMed ID: 19356597
[TBL] [Abstract][Full Text] [Related]
14. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
Jellinger KA
Acta Neuropathol; 2009 Feb; 117(2):215-6; author reply 217-8. PubMed ID: 18985364
[No Abstract] [Full Text] [Related]
15. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene.
Yamaguchi K; Cochran EJ; Murrell JR; Polymeropoulos MH; Shannon KM; Crowther RA; Goedert M; Ghetti B
Acta Neuropathol; 2005 Sep; 110(3):298-305. PubMed ID: 15981014
[TBL] [Abstract][Full Text] [Related]
16. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease.
Huisman E; Uylings HB; Hoogland PV
Mov Disord; 2004 Jun; 19(6):687-92. PubMed ID: 15197709
[TBL] [Abstract][Full Text] [Related]
17. Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease.
Braak H; Sastre M; Del Tredici K
Acta Neuropathol; 2007 Sep; 114(3):231-41. PubMed ID: 17576580
[TBL] [Abstract][Full Text] [Related]
18. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
[TBL] [Abstract][Full Text] [Related]
19. Localization of CKII beta subunits in Lewy bodies of Parkinson's disease.
Ryu MY; Kim DW; Arima K; Mouradian MM; Kim SU; Lee G
J Neurol Sci; 2008 Mar; 266(1-2):9-12. PubMed ID: 17884098
[TBL] [Abstract][Full Text] [Related]
20. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
Schell H; Hasegawa T; Neumann M; Kahle PJ
Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
